A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The …
R Scott, J Morgan, Z Zimmer, RLH Lam… - Diabetes, Obesity …, 2018 - Wiley Online Library
… The results of this clinical trial may be of particular interest to physicians treating older …
together with potentially longer duration of diabetes, older patients are likely to be at increased risk …
together with potentially longer duration of diabetes, older patients are likely to be at increased risk …
… according to baseline kidney function and albuminuria status in patients with type 2 diabetes: a prespecified secondary analysis of a randomized clinical trial
TA Zelniker, I Raz, O Mosenzon, JP Dwyer… - JAMA …, 2021 - jamanetwork.com
… medical therapy, enrolling patients from May 2013 to June 2015. Eligible patients with
established ASCVD had to be 40 years of age or older … older and women 60 years of age or older …
established ASCVD had to be 40 years of age or older … older and women 60 years of age or older …
Twice‐daily dapagliflozin co‐administered with metformin in type 2 diabetes: a 16‐week randomized, placebo‐controlled clinical trial
PM Schumm‐Draeger, L Burgess… - Diabetes, Obesity …, 2015 - Wiley Online Library
… The last study visit followed this period. … Similarly, in the present study, a small initial
decrease in eGFR with dapagliflozin was observed for all treatment groups and this did not appear …
decrease in eGFR with dapagliflozin was observed for all treatment groups and this did not appear …
… care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24‐week, multicenter, randomized, double‐blind, placebo‐controlled study …
LA Leiter, WT Cefalu, TWA de Bruin… - Journal of the …, 2014 - Wiley Online Library
… ) 60–89 mL/min per 1.73 m 2 , 61%; moderate eGFR 30–59 mL/min per 1.73 m 2 , 15%) was
observed at baseline in the present study than in previous placebo-controlled dapagliflozin …
observed at baseline in the present study than in previous placebo-controlled dapagliflozin …
Dapagliflozin treatment for type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials
M Zhang, L Zhang, B Wu, H Song… - … /metabolism research …, 2014 - Wiley Online Library
… Randomized controlled trials (RCTs), with treatment interventions that lasted at least 12 weeks,
were collected. Non-human studies, letters… The last observations carried out were used to …
were collected. Non-human studies, letters… The last observations carried out were used to …
Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled …
E Papadopoulou, C Loutradis, G Tzatzagou… - Journal of …, 2021 - journals.lww.com
… a difference between the dapagliflozin and placebo group of … With last patient last visit for
the study planned for September … trial with last randomized patient at March 2019 and a study …
the study planned for September … trial with last randomized patient at March 2019 and a study …
The effect of dapagliflozin treatment on epicardial adipose tissue volume and P-wave indices: an ad-hoc analysis of the previous randomized clinical trial
T Sato, Y Aizawa, S Yuasa, S Fujita, Y Ikeda… - … of atherosclerosis and …, 2020 - jstage.jst.go.jp
… This study investigated the effect of dapagliflozin on EAT volume and P-wave indices. …
present study were 48 ms and 15 ms in the dapagliflozin group and 44 ms and 14 ms in the control …
present study were 48 ms and 15 ms in the dapagliflozin group and 44 ms and 14 ms in the control …
… dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a randomized, placebo‐controlled …
… indicate that dapagliflozin treatment reduced cardiac preload and are in line with recent
findings of … Björkgren, Uppsala Clinical Research Center, for valuable support with editing and …
findings of … Björkgren, Uppsala Clinical Research Center, for valuable support with editing and …
Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial
…, A Grohl, S Parikh, Study 05 Group - … Care, 2015 - Am Diabetes Assoc
… The treatment groups were generally balanced with respect to demographics … dapagliflozin
treatment arm (Table 1). Most patients were white, had a mean age of 61 years, had a prior …
treatment arm (Table 1). Most patients were white, had a mean age of 61 years, had a prior …
A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
AJM Brown, S Gandy, R McCrimmon… - European heart …, 2020 - academic.oup.com
… In this ‘proof of concept’ randomized controlled trial, we hypothesized that dapagliflozin
would … Participants had to have an HbA1c measurement within the last 6 months at screening …
would … Participants had to have an HbA1c measurement within the last 6 months at screening …
相关搜索
- previous randomized clinical trial tissue volume
- meta analysis of randomized controlled trials
- randomized controlled trial safety of dapagliflozin
- randomised controlled trials efficacy of dapagliflozin
- effect of dapagliflozin randomized clinical trial
- randomized controlled trial dapagliflozin monotherapy
- previous randomized clinical trial ad hoc
- sglt2 inhibitor dapagliflozin randomized controlled trials
- randomized controlled trial two diabetes
- randomised controlled trials hypoglycaemic drugs
- mild renal insufficiency randomized clinical trial
- albuminuria status randomized clinical trial
- baseline kidney function randomized clinical trial
- prespecified secondary analysis randomized clinical trial
- cardiovascular outcomes randomized clinical trial
- type 2 diabetes randomized clinical trial